Posts - Bill - HRES 803 Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
house 10/10/2025 - 119th Congress
We are calling on the FDA to reassess the safety of chemical abortion drugs based on new independent research that suggests higher risks than previously reported. Our goal is to ensure transparent, accurate information about these drugs to better protect women’s health and uphold existing laws.
Congress.gov
HRES 803 - Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Views
moderate 10/10/2025
Reevaluating drug safety is common sense, but don’t let it become a political weapon.
right-leaning 10/10/2025
Abortion isn’t just about choice—it’s about truth, safety, and protecting the unborn.
left-leaning 10/10/2025
This bill just masks a sneaky attempt to squeeze women’s rights through the budget window.
moderate 10/10/2025
If they want trust, start with honest data — not scare tactics dressed as concern.
right-leaning 10/10/2025
When ‘access’ means risking women’s lives, it’s time to hit pause and review the facts.
right-leaning 10/10/2025
Finally, someone’s calling out the FDA for sweeping chemical abortion dangers under the rug.
moderate 10/10/2025
Everyone deserves transparency, but let’s hope this review is about science, not showmanship.
left-leaning 10/10/2025
If safety was the real goal, why ignore the science that keeps abortion legal and safe?
left-leaning 10/10/2025
Using ‘independent studies’ to stall abortion access is just fear-mongering in a lab coat.